Live Now

  • [UAE News]Mohamed bin Zayed, Slovak President discuss bilateral ties ...Read More
  • [UAE News]Mohammed bin Rashid visits Arab Health and Medlab Middle East 2022 ...Read More
  • [UAE News]Noura Al Kaabi launches World Poetry Tree Anthology at Expo 2020 Dubai ...Read More
  • [UAE News]UAE industrial exports hit AED120 billion, with 220 new factories going into service and beginning production: Sultan Al Jaber ...Read More
  • [UAE News]Executive Council of Dubai approves Integrated Waste Management Strategy 2021-2041, with a budget of AED74.5 billion ...Read More
  • [UAE News]COVID-19 media briefing: UAE a distinguished model of containing COVID variants ...Read More
  • [UAE News]UAE resumes entry for travellers from 12 African countries, updates entry measures with another 3 effective January 29 ...Read More
  • [UAE News]UAE-Egypt-Bahrain summit deliberates regional issues ...Read More
  • [UAE News]Sultan bin Ahmed attends '50 Years of Sultan's Love' ceremony ...Read More
  • [Business ]Etisalat named world's strongest telecom brand with US$12.5 bn portfolio ...Read More

our News

UAE detects first case of COVID-19 Omicron variant

  • UAE News
  • 02 Dec 2021
  • 12:00 AM

The Ministry of Health and Prevention (MoHAP) has announced the detection of the first case of the COVID-19 Omicron variant in an African woman coming from an African country via an Arab nation. The detected case is fully vaccinated against COVID-19 as per the approved health protocols in place in the UAE. MoHAP said the infected case has been examined and isolated along with her contacts, adding that the patient is exhibiting no symptoms of the disease and that all the necessary health measures have been taken. The Ministry affirmed that the UAE Health Sector is fully prepared to address various COVID-19 variants by taking all proactive measures through inspection and conducting all necessary tests. The Ministry also reiterated the importance of taking the COVID vaccination, including the booster shot, in order to ensure immunity and protection of COVID-19–related fatalities or severe symptoms, specially in light of the emergence of new variants.